REXIGUT 550 Tablet 10’s

Description

REXIGUT 550 Tablet is a broad-spectrum, semi-synthetic antibiotic derived from rifamycin class of drugs. it is primarily used to treat infections and conditions involving the gastrointestinal (gi) tract because of its unique property of acting locally within the intestines with minimal systemic absorption. this makes it particularly useful for targeting intestinal bacteria while reducing the risk of widespread systemic side effects commonly associated with other antibiotics.

the mechanism of action of REXIGUT 550 Tablet involves inhibition of bacterial rna synthesis. it binds to the β-subunit of bacterial dna-dependent rna polymerase enzyme, thereby blocking transcription and preventing the production of essential proteins required for bacterial survival and multiplication. as a result, it effectively reduces the growth of susceptible bacteria, especially gram-positive and gram-negative organisms found in the gut. because it remains largely confined to the gastrointestinal lumen, it acts directly at the site of infection or bacterial imbalance.

this medicine is widely prescribed for several gastrointestinal conditions, including traveler’s diarrhea caused by non-invasive strains of escherichia coli, irritable bowel syndrome with diarrhea (ibs-d), and to reduce the risk of recurrence of hepatic encephalopathy in patients with chronic liver disease. it is also sometimes used off-label in small intestinal bacterial overgrowth (sibo). due to its localized action and favorable safety profile, REXIGUT 550 Tablet is often preferred when long-term modulation of gut flora is required without significant systemic exposure.

REXIGUT 550 Tablet plays an important role in restoring intestinal microbial balance. in conditions like ibs-d and sibo, there is often an overgrowth or imbalance of gut bacteria that contributes to symptoms such as bloating, abdominal discomfort, and irregular bowel movements. by reducing bacterial load in the intestines, REXIGUT 550 Tablet helps alleviate these symptoms and improves overall gut function. however, it is not effective for infections that have spread beyond the intestines or for systemic bacterial infections.

ingredients

• REXIGUT 550 Tablet: the active pharmaceutical ingredient (api) in this medicine. it works as a non-absorbable antibiotic that stays mostly in the gastrointestinal tract. it inhibits bacterial rna synthesis, thereby stopping bacterial growth and reducing harmful bacterial populations in the intestines. its localized action helps in treating gut-related infections and conditions while minimizing systemic side effects.
• inactive ingredients (excipients): depending on the formulation, REXIGUT 550 Tablet tablets may contain binders, stabilizers, coloring agents, and fillers such as microcrystalline cellulose, magnesium stearate, silicon dioxide, and other pharmaceutical-grade excipients. these components help in maintaining tablet integrity, stability, and proper drug release but do not contribute to therapeutic effects.

key uses

• treatment of traveler’s diarrhea caused by non-invasive strains of escherichia coli, helping reduce frequency of loose stools and abdominal discomfort.
• management of irritable bowel syndrome with diarrhea (ibs-d), where it helps reduce bloating, abdominal pain, and irregular bowel habits by modulating gut bacteria.
• prevention of hepatic encephalopathy recurrence in patients with chronic liver disease by reducing ammonia-producing gut bacteria.
• management of small intestinal bacterial overgrowth (sibo), where bacterial overgrowth in the small intestine leads to digestive discomfort and malabsorption symptoms.
• adjunct therapy in certain gastrointestinal conditions where bacterial imbalance contributes to chronic digestive symptoms.

how to use

REXIGUT 550 Tablet should be used strictly according to a healthcare provider’s instructions. it is generally taken orally in tablet form with or without food, although taking it with food may help reduce mild stomach discomfort in some individuals. the tablet should be swallowed whole with water and should not be crushed or chewed unless directed by a physician.

the duration of therapy depends on the medical condition being treated. for example, short-term courses are commonly used for traveler’s diarrhea, while longer or repeated courses may be required for conditions like ibs-d or hepatic encephalopathy prevention. it is important to complete the prescribed course even if symptoms improve earlier, as stopping prematurely may lead to recurrence of infection or bacterial imbalance.

patients are advised to maintain adequate hydration during treatment, especially if the medicine is being used for diarrhea-related conditions. if symptoms persist beyond the expected treatment period or worsen, medical consultation is necessary to reassess the condition and rule out other causes.

safety information

• warnings: REXIGUT 550 Tablet should not be used for systemic bacterial infections or infections that have spread beyond the gastrointestinal tract. overuse or inappropriate use may reduce its effectiveness and contribute to antibiotic resistance. it should only be used when prescribed by a healthcare professional.
• side effects: common side effects include nausea, abdominal pain, bloating, headache, dizziness, and flatulence. serious side effects are rare but may include severe allergic reactions such as rash, itching, swelling, or difficulty breathing. in rare cases, clostridioides difficile-associated diarrhea may occur due to disruption of gut flora.
• precautions: patients with severe liver impairment should use REXIGUT 550 Tablet under strict medical supervision. individuals with known hypersensitivity to rifamycin-class antibiotics should avoid this medication. caution is advised in patients with intestinal obstruction or severe gastrointestinal conditions.
• pregnancy/breastfeeding: REXIGUT 550 Tablet is generally considered to have limited systemic absorption, but its use during pregnancy should only be considered if clearly needed and prescribed by a healthcare provider. it is not known whether it passes into breast milk in significant amounts; therefore, caution is advised during breastfeeding.
• interactions: although REXIGUT 550 Tablet has minimal systemic absorption, it may still interact with certain medications that affect gut flora or liver enzyme activity. concomitant use with other antibiotics or medications affecting intestinal motility should be monitored. alcohol does not have a direct interaction but may worsen gastrointestinal symptoms and should be avoided or minimized during treatment.

additional information

• storage: store REXIGUT 550 Tablet at room temperature, away from moisture, heat, and direct sunlight. keep it in its original packaging and out of reach of children. do not use expired medication.
• missed dose: if a dose is missed, it should be taken as soon as remembered. however, if it is close to the time of the next scheduled dose, the missed dose should be skipped. do not double the dose to make up for a missed one.
• overdose: overdose with REXIGUT 550 Tablet is unlikely to cause severe toxicity due to its poor systemic absorption, but excessive intake may lead to gastrointestinal disturbances such as nausea, vomiting, or diarrhea. in case of suspected overdose, medical attention should be sought immediately.
• habit forming: REXIGUT 550 Tablet is not habit-forming. it does not cause dependence or addiction, as it is an antibiotic and not a controlled psychoactive substance.

frequently asked questions

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.